ArticleCardiology and therapy2026

ACO-SWITCH: Rationale and Design of a Phase 4 Study Evaluating Serum Transthyretin in ATTR-CM After Switching from Tafamidis to Acoramidis.

Roman Pfister et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.